Vivek Subbiah, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, relates an enthusiastic joy at the opportunity to attend AACR 2022 in person and to experience presentations on exciting novel fields in oncology including targeted therapies, immunotherapies and epigenetic therapies. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.